New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export SBRA’s income statement to Excel — free account
Sabra Healthcare REIT, Inc.
SBRAReal Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.
- Revenue
- +31.3%
- EPS
- +22.2%
- Free cash flow
- n/m
- Total debt
- −5.99%
Quarter to September 2026, against a year earlier
20.39
0.07
−0.34%
After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.
Follow SBRA
Alert me
Revenue to profit Q3 FY2026, quarter to Sep 30, 2026
Of every $100 of revenue, $11.44 was left as profit. What is an income statement?
| Revenue | 249.6 | 100.0% |
|---|---|---|
| Cost of revenue | 0.0 | 0.0% |
| Gross profit | 249.6 | 100.0% |
| Selling, general & admin | −15.6 | −6.2% |
| Other operating costs | −170.1 | −68.2% |
| Operating income | 63.9 | 25.6% |
| Other income, net | −37.5 | −15.0% |
| Other items | +2.2 | 0.9% |
| Net income | 28.6 | 11.4% |
Net margin (right axis)
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | $212M | $222M | $236M | $250M |
| Operating income | $64M | $68M | −$32M | $64M |
| Net income | $27M | $41M | −$25M | $29M |
| Net margin (right axis) | 12.8% | 18.4% | −10.7% | 11.4% |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Revenue |
+8 more quarters Free account |
211.90 | 221.75 | 235.87 | 249.57 |
Revenue Growth |
16.21% | 20.82% | 24.70% | 31.32% | |
Gross Profit |
211.90 | 221.75 | 235.87 | 249.57 | |
SG&A Expenses |
15.91 | 14.86 | 16.82 | 15.58 | |
Operating Income |
63.93 | 67.89 | (32.05) | 63.87 | |
Non-operating Interest Expenses |
28.94 | 28.41 | 29.78 | 29.16 | |
Non-operating Income/Expense |
(37.94) | (28.46) | 5.26 | (37.48) | |
Investment Gain/Loss (Other) |
1.65 | 1.91 | 2.22 | 2.23 | |
| 25.99 | 39.43 | (26.79) | 26.40 | ||
Income Tax Provision |
0.49 | 0.53 | 0.68 | 0.07 | |
Income after Tax |
25.50 | 38.90 | (27.47) | 26.33 | |
Dividends (Preferred) |
— | — | — | 0.00 | |
Non-Controlling Interest |
(0.08) | (0.07) | (0.05) | (0.05) | |
Net Income Common |
27.23 | 40.88 | (25.20) | 28.61 | |
EPS (Basic) |
0.11 | 0.16 | (0.10) | 0.11 | |
EPS (Diluted) |
0.11 | 0.16 | (0.10) | 0.11 | |
Shares (Basic, Weighted) |
241.31 | 252.14 | 252.27 | 255.60 | |
Shares (Diluted, Weighted) |
244.50 | 255.97 | 252.27 | 259.82 | |
Gross Margin |
100.00% | 100.00% | 100.00% | 100.00% | |
EBIT Margin |
30.17% | 30.62% | (13.59%) | 25.59% | |
EBT margin |
12.26% | 17.78% | (11.36%) | 10.58% | |
Net Profit Margin |
12.85% | 18.43% | (10.68%) | 11.46% | |
EBITDA |
115.34 | 121.02 | 24.33 | 128.65 | |
EBIT |
63.93 | 67.89 | (32.05) | 63.87 | |
Income from Continuous Operations |
27.15 | 40.81 | (25.25) | 28.56 | |
Consolidated Net Income/Loss |
27.15 | 40.81 | (25.25) | 28.56 | |
EPS (Basic, from Continuous Ops) |
0.11 | 0.16 | (0.10) | 0.11 | |
EPS (Diluted, from Cont. Ops) |
0.10 | 0.16 | (0.10) | 0.11 | |
EPS (Basic, Consolidated) |
0.11 | 0.16 | (0.10) | 0.11 | |
EPS (Diluted, Consolidated) |
0.10 | 0.16 | (0.10) | 0.11 | |
Shares (Diluted, Average) |
252.77 | 255.97 | 252.27 | 259.82 | |
EBITDA Margin |
54.43% | 54.58% | 10.32% | 51.55% | |
Operating Cash Flow Margin |
41.26% | 44.36% | 36.39% | 51.68% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026